Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Synaptic vesicle release regulates myelin sheath number of individual oligodendrocytes in vivo.
Aptamer Oligonucleotides: Novel Potential Therapeutic Agents in Autoimmune Disease.
Paraneoplastic Neuromyelitis Optica Spectrum Disorders: Three New Cases and A Review of the Literature.
Cardiopulmonary fitness is related to disease severity in multiple sclerosis.
Sociocultural and Demographic Risk Factors for the Development of Multiple Sclerosis in Kuwait: A Case - Control Study.
Epigenetics and the Modulation of Neuroinflammation.
Finding the missing link in neuromyelitis optica presenting with recurrent transverse myelitis flares.
New and emerging immune-targeted drugs for the treatment of multiple sclerosis.
Burden of disease in multiple sclerosis patients with spasticity in Germany: mobility improvement study (Move I).
Potential role of 8-oxoguanine DNA glycosylase 1 as a STAT1 coactivator in endotoxin-induced inflammatory response.
Silencing of Abcc8 or inhibition of newly upregulated Sur1-Trpm4 reduce inflammation and disease progression in experimental autoimmune encephalomyelitis.
Bioinformatics Mining and Modeling Methods for the Identification of Disease Mechanisms in Neurodegenerative Disorders.
Prevalence of brain magnetic resonance imaging meeting Barkhof and McDonald criteria for dissemination in space among headache patients.
Contribution of cortical and white matter lesions to cognitive impairment in multiple sclerosis.
Assessing possible selection bias in a national voluntary MS longitudinal study in Australia.
Assessing the Correlation between Grey and White Matter Damage with Motor and Cognitive Impairment in Multiple Sclerosis Patients.
Using historical control information for the design and analysis of clinical trials with overdispersed count data.
How does fingolimod (gilenya(®)) fit in the treatment algorithm for highly active relapsing-remitting multiple sclerosis?
Autoimmune disorders after immunisation with Influenza A/H1N1 vaccines with and without adjuvant: EudraVigilance data and literature review.
Differentiation of neuromyelitis optica from multiple sclerosis in a cohort from the mainland of China.
Goal attainment in cognitive rehabilitation in MS patients.
New therapeutic approach by G2013 in experimental model of multiple sclerosis.
The risk of cancer from azathioprine as a treatment for multiple sclerosis.
Neutrophil-related factors as biomarkers in EAE and MS.
Oral drugs in multiple sclerosis therapy: an overview and a critical appraisal.
Pages
« first
‹ previous
…
428
429
430
431
432
433
434
435
436
…
next ›
last »